Skip to main content
INDP
NASDAQ Life Sciences

Decoy20 Enrollment Halted as Indaptus Winds Down Clinical Work

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$3.1
Mkt Cap
$486.853M
52W Low
$0.92
52W High
$5.96
52W Position info
237% above low
Off High info
48% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

INDP has more than doubled off its 52-week low of $0.92 on light trading volume (0.1× avg).

Summary

Indaptus has stopped enrolling patients in its Decoy20 combination study and wound down the related clinical work, leaving no patients in active trials while it reassesses strategy. That is the material new fact here — the $24.0 million private placement it completed was already disclosed in the September 10 8-K, and the Q3 10-Q filed November 13 noted no active clinical program. The company now says the placement proceeds will fund operations and exploratory research into a sleep device, a sharp pivot away from the immunotherapy pipeline that defined the thesis. With the going-concern doubt resolved on $26.6 million in cash plus $4.0 million in CDs and $3.5 million received in October, the balance sheet buys time, but there is no clinical readout left to trade against.

At the time of this announcement, INDP was trading at $3.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $486.9M. The 52-week trading range was $0.92 to $5.96. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

INDP - Latest Insights

INDP
Nov 13, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.17
Real-time Price: $3.40 info
Change: +$0.230 (+7%) info
Market Cap: $529.855M info
INDP
Nov 13, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.15
Real-time Price: $3.40 info
Change: +$0.250 (+8%) info
Market Cap: $529.855M info
INDP
Sep 09, 2026, 9:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.11
Real-time Price: $3.40 info
Change: +$1.29 (+61%) info
Market Cap: $529.855M info
INDP
Aug 31, 2026, 9:25 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $3.40 info
Change: +$2.26 (+198%) info
Market Cap: $529.855M info
INDP
Aug 26, 2026, 4:35 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $3.40 info
Change: +$2.24 (+193%) info
Market Cap: $529.855M info